Similar articles for PMID: 25923243

Year	Number of Results
1957	1
2002	1
2006	2
2007	3
2008	1
2009	3
2010	1
2011	6
2012	9
2013	7
2014	12
2015	10
2016	1
2021	1
2023	1
2024	0

1

Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.

Sise ME, Backman ES, Wenger JB, Wood BR, Sax PE, Chung RT, Thadhani R, Kim AY. Sise ME, et al. PLoS One. 2015 Apr 29;10(4):e0124139. doi: 10.1371/journal.pone.0124139. eCollection 2015. PLoS One. 2015. PMID: 25923243 Free PMC article.

2

eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?

Loustaud-Ratti V, Rousseau A, Carrier P, Vong C, Chambaraud T, Jacques J, Debette-Gratien M, Sautereau D, Essig M. Loustaud-Ratti V, et al. Liver Int. 2015 Jan;35(1):71-8. doi: 10.1111/liv.12631. Epub 2014 Jul 28. Liver Int. 2015. PMID: 25039814 Clinical Trial.

3

Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients.

Van den Eynde E, Curto J, Ferrer E, Imaz A, Saumoy M, Di Yacovo S, Vila A, Podzamczer D. Van den Eynde E, et al. AIDS. 2015 May 15;29(8):977-9. doi: 10.1097/QAD.0000000000000643. AIDS. 2015. PMID: 25784438

4

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir.

Mauss S, Hueppe D, Alshuth U. Mauss S, et al. Hepatology. 2014 Jan;59(1):46-8. doi: 10.1002/hep.26602. Epub 2013 Nov 11. Hepatology. 2014. PMID: 23813604 Clinical Trial.

5

Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?

Matsui K, Kamijo-Ikemori A, Sugaya T, Ikeda H, Okuse C, Shibagaki Y, Yasuda T, Kimura K. Matsui K, et al. Nephrology (Carlton). 2015 Nov;20(11):843-8. doi: 10.1111/nep.12517. Nephrology (Carlton). 2015. PMID: 25998031

6

Renal dysfunction associated with telaprevir-containing triple therapy for chronic hepatitis C: is early prediction possible?

Rémy AJ, Lesgourgues B, Nalet B, Causse X, Henrion J, Denis J, Arotçarena R, Hagège H, Pariente A; APROVVIE group of Association Nationale des Gastroentérologues des Hôpitaux Généraux (ANGH). Rémy AJ, et al. Eur J Gastroenterol Hepatol. 2014 Sep;26(9):996-1002. doi: 10.1097/MEG.0000000000000081. Eur J Gastroenterol Hepatol. 2014. PMID: 25072384

7

Predictors of outcome for renal artery stenting performed for salvage of renal function.

Modrall JG, Timaran CH, Rosero EB, Chung J, Arko FA 3rd, Valentine RJ, Clagett GP, Trimmer C. Modrall JG, et al. J Vasc Surg. 2011 Nov;54(5):1414-1421.e1; discussion 1420-1. doi: 10.1016/j.jvs.2011.04.042. Epub 2011 Jul 31. J Vasc Surg. 2011. PMID: 21803522 Free article.

8

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

Coilly A, Roche B, Dumortier J, Leroy V, Botta-Fridlund D, Radenne S, Pageaux GP, Si-Ahmed SN, Guillaud O, Antonini TM, Haïm-Boukobza S, Roque-Afonso AM, Samuel D, Duclos-Vallée JC. Coilly A, et al. J Hepatol. 2014 Jan;60(1):78-86. doi: 10.1016/j.jhep.2013.08.018. Epub 2013 Aug 29. J Hepatol. 2014. PMID: 23994384

9

Cardiovascular disease and subsequent kidney disease.

Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, Sarnak MJ, Weiner DE. Elsayed EF, et al. Arch Intern Med. 2007 Jun 11;167(11):1130-6. doi: 10.1001/archinte.167.11.1130. Arch Intern Med. 2007. PMID: 17563020

10

Telaprevir: a hepatitis C NS3/4A protease inhibitor.

Matthews SJ, Lancaster JW. Matthews SJ, et al. Clin Ther. 2012 Sep;34(9):1857-82. doi: 10.1016/j.clinthera.2012.07.011. Epub 2012 Aug 28. Clin Ther. 2012. PMID: 22951253 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year